Anne Libby
Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicaid | 12 | 2024 | 459 | 1.530 |
Why?
| | Mental Health Services | 12 | 2016 | 462 | 1.430 |
Why?
| | Financing, Organized | 4 | 2020 | 36 | 1.230 |
Why?
| | Research Personnel | 5 | 2020 | 187 | 1.070 |
Why?
| | Comparative Effectiveness Research | 4 | 2013 | 165 | 0.980 |
Why?
| | Indians, North American | 6 | 2008 | 658 | 0.840 |
Why?
| | Nonprescription Drugs | 3 | 2016 | 65 | 0.830 |
Why?
| | Substance-Related Disorders | 8 | 2008 | 1083 | 0.780 |
Why?
| | Biomedical Research | 5 | 2020 | 716 | 0.770 |
Why?
| | Antidepressive Agents | 6 | 2015 | 240 | 0.760 |
Why?
| | Managed Care Programs | 10 | 2011 | 135 | 0.750 |
Why?
| | Sex Factors | 8 | 2025 | 2090 | 0.710 |
Why?
| | Depressive Disorder | 6 | 2015 | 368 | 0.690 |
Why?
| | Faculty, Medical | 4 | 2022 | 300 | 0.670 |
Why?
| | Mentoring | 3 | 2022 | 165 | 0.660 |
Why?
| | Capitation Fee | 5 | 2002 | 14 | 0.640 |
Why?
| | Interdisciplinary Research | 1 | 2020 | 26 | 0.630 |
Why?
| | Mental Disorders | 5 | 2017 | 1137 | 0.590 |
Why?
| | Sex Characteristics | 3 | 2022 | 790 | 0.560 |
Why?
| | Antihypertensive Agents | 4 | 2025 | 500 | 0.550 |
Why?
| | United States Food and Drug Administration | 4 | 2009 | 201 | 0.550 |
Why?
| | Emergency Services, Psychiatric | 1 | 2017 | 15 | 0.530 |
Why?
| | Pharmacists | 2 | 2024 | 241 | 0.520 |
Why?
| | Child Welfare | 4 | 2007 | 231 | 0.510 |
Why?
| | Academic Medical Centers | 3 | 2020 | 542 | 0.500 |
Why?
| | Writing | 1 | 2018 | 100 | 0.500 |
Why?
| | Interdisciplinary Studies | 1 | 2016 | 30 | 0.500 |
Why?
| | Prescription Drugs | 2 | 2016 | 111 | 0.490 |
Why?
| | Academies and Institutes | 1 | 2016 | 61 | 0.480 |
Why?
| | Mentors | 5 | 2022 | 218 | 0.470 |
Why?
| | Child Abuse | 6 | 2008 | 550 | 0.460 |
Why?
| | Contract Services | 3 | 2002 | 11 | 0.450 |
Why?
| | Science | 1 | 2016 | 56 | 0.450 |
Why?
| | United States | 31 | 2025 | 15723 | 0.450 |
Why?
| | Fee-for-Service Plans | 5 | 2002 | 89 | 0.440 |
Why?
| | Health Policy | 5 | 2016 | 391 | 0.430 |
Why?
| | Quality-Adjusted Life Years | 3 | 2014 | 116 | 0.430 |
Why?
| | Colorado | 17 | 2020 | 4605 | 0.430 |
Why?
| | Child Abuse, Sexual | 3 | 2007 | 81 | 0.420 |
Why?
| | Juvenile Delinquency | 3 | 2004 | 99 | 0.420 |
Why?
| | Health Care Costs | 2 | 2010 | 418 | 0.410 |
Why?
| | Dibenzothiazepines | 1 | 2013 | 16 | 0.410 |
Why?
| | Data Collection | 5 | 2012 | 638 | 0.400 |
Why?
| | Medication Therapy Management | 1 | 2014 | 72 | 0.400 |
Why?
| | Cooperative Behavior | 1 | 2016 | 463 | 0.390 |
Why?
| | Humans | 77 | 2025 | 144857 | 0.390 |
Why?
| | Length of Stay | 2 | 2017 | 1321 | 0.380 |
Why?
| | Videoconferencing | 2 | 2017 | 66 | 0.380 |
Why?
| | Telemedicine | 2 | 2024 | 952 | 0.380 |
Why?
| | Adolescent | 33 | 2017 | 22396 | 0.370 |
Why?
| | Cohort Studies | 13 | 2016 | 5898 | 0.370 |
Why?
| | Male | 49 | 2025 | 72189 | 0.370 |
Why?
| | Physicians | 4 | 2022 | 936 | 0.360 |
Why?
| | Suicide, Attempted | 3 | 2015 | 385 | 0.360 |
Why?
| | Antipsychotic Agents | 1 | 2013 | 185 | 0.350 |
Why?
| | Female | 51 | 2025 | 78217 | 0.350 |
Why?
| | Cities | 1 | 2012 | 143 | 0.350 |
Why?
| | Income | 1 | 2012 | 198 | 0.350 |
Why?
| | Unemployment | 1 | 2010 | 44 | 0.330 |
Why?
| | Practice Patterns, Physicians' | 5 | 2025 | 1332 | 0.320 |
Why?
| | Plant Preparations | 1 | 2010 | 37 | 0.320 |
Why?
| | Research Support as Topic | 3 | 2020 | 79 | 0.320 |
Why?
| | Cost of Illness | 1 | 2012 | 321 | 0.310 |
Why?
| | Tobacco Smoke Pollution | 1 | 2012 | 237 | 0.300 |
Why?
| | Depression | 3 | 2014 | 1536 | 0.300 |
Why?
| | Cost-Benefit Analysis | 6 | 2017 | 621 | 0.290 |
Why?
| | Prescriptions | 1 | 2009 | 76 | 0.290 |
Why?
| | Polypharmacy | 2 | 2024 | 90 | 0.290 |
Why?
| | Hypertension | 3 | 2025 | 1241 | 0.290 |
Why?
| | Multivariate Analysis | 6 | 2017 | 1510 | 0.280 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5809 | 0.280 |
Why?
| | Child, Preschool | 14 | 2017 | 11740 | 0.270 |
Why?
| | Point-of-Care Systems | 1 | 2010 | 187 | 0.270 |
Why?
| | Middle Aged | 29 | 2025 | 35939 | 0.270 |
Why?
| | Epilepsy | 1 | 2012 | 376 | 0.270 |
Why?
| | Health Maintenance Organizations | 2 | 2005 | 103 | 0.270 |
Why?
| | Premature Birth | 1 | 2012 | 383 | 0.270 |
Why?
| | Child | 24 | 2017 | 22620 | 0.270 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2007 | 882 | 0.270 |
Why?
| | Chronic Disease | 2 | 2013 | 1833 | 0.260 |
Why?
| | Drug and Narcotic Control | 1 | 2007 | 24 | 0.260 |
Why?
| | Combat Disorders | 1 | 2007 | 41 | 0.260 |
Why?
| | Interview, Psychological | 1 | 2007 | 94 | 0.260 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2009 | 186 | 0.250 |
Why?
| | Research Design | 3 | 2019 | 1128 | 0.250 |
Why?
| | Health Services Accessibility | 3 | 2007 | 1092 | 0.240 |
Why?
| | Education, Medical | 2 | 2020 | 274 | 0.240 |
Why?
| | Parents | 3 | 2017 | 1424 | 0.240 |
Why?
| | Health Behavior | 1 | 2012 | 795 | 0.240 |
Why?
| | Longitudinal Studies | 8 | 2016 | 2971 | 0.240 |
Why?
| | Adult | 26 | 2025 | 40438 | 0.230 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1089 | 0.230 |
Why?
| | Decision Making | 1 | 2013 | 970 | 0.230 |
Why?
| | Hypoglycemia | 1 | 2010 | 479 | 0.220 |
Why?
| | Retrospective Studies | 13 | 2025 | 16937 | 0.220 |
Why?
| | Aged | 20 | 2025 | 25822 | 0.220 |
Why?
| | Smoking | 1 | 2012 | 1557 | 0.210 |
Why?
| | Aged, 80 and over | 9 | 2024 | 8185 | 0.210 |
Why?
| | Stress, Psychological | 2 | 2010 | 1154 | 0.210 |
Why?
| | Family | 2 | 2006 | 693 | 0.210 |
Why?
| | Crime | 1 | 2004 | 61 | 0.210 |
Why?
| | Parenting | 1 | 2008 | 325 | 0.200 |
Why?
| | Ambulatory Care | 4 | 2014 | 599 | 0.200 |
Why?
| | Rural Population | 2 | 2007 | 651 | 0.200 |
Why?
| | Curriculum | 3 | 2020 | 1058 | 0.200 |
Why?
| | Suicide | 3 | 2007 | 681 | 0.200 |
Why?
| | Deprescriptions | 1 | 2024 | 34 | 0.200 |
Why?
| | Residential Treatment | 1 | 2002 | 26 | 0.180 |
Why?
| | Primary Health Care | 4 | 2024 | 1763 | 0.180 |
Why?
| | Adolescent Psychiatry | 1 | 2002 | 14 | 0.180 |
Why?
| | Brain Injuries | 2 | 2005 | 507 | 0.170 |
Why?
| | Anxiety Disorders | 1 | 2005 | 365 | 0.170 |
Why?
| | Foster Home Care | 1 | 2003 | 88 | 0.170 |
Why?
| | Criminal Law | 1 | 2002 | 31 | 0.170 |
Why?
| | Logistic Models | 6 | 2017 | 2098 | 0.170 |
Why?
| | Contracts | 1 | 2001 | 11 | 0.170 |
Why?
| | Child Psychiatry | 1 | 2002 | 35 | 0.170 |
Why?
| | Electronic Health Records | 3 | 2015 | 1177 | 0.170 |
Why?
| | Schizophrenia | 1 | 2005 | 435 | 0.170 |
Why?
| | Infant | 9 | 2017 | 9987 | 0.170 |
Why?
| | Blood Pressure | 2 | 2025 | 1752 | 0.170 |
Why?
| | Costs and Cost Analysis | 3 | 2010 | 215 | 0.170 |
Why?
| | Health Surveys | 3 | 2010 | 512 | 0.170 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 554 | 0.170 |
Why?
| | Surface Plasmon Resonance | 1 | 2021 | 91 | 0.160 |
Why?
| | Severity of Illness Index | 6 | 2014 | 2940 | 0.160 |
Why?
| | Women's Health | 2 | 2020 | 311 | 0.160 |
Why?
| | Hypoglycemic Agents | 1 | 2010 | 1398 | 0.160 |
Why?
| | Organizational Innovation | 2 | 2020 | 127 | 0.160 |
Why?
| | Dementia | 1 | 2024 | 299 | 0.150 |
Why?
| | Dried Blood Spot Testing | 1 | 2021 | 126 | 0.150 |
Why?
| | Education | 1 | 2020 | 108 | 0.150 |
Why?
| | Population Groups | 3 | 2017 | 58 | 0.150 |
Why?
| | Organophosphates | 1 | 2021 | 185 | 0.150 |
Why?
| | Young Adult | 10 | 2017 | 14033 | 0.150 |
Why?
| | Interdisciplinary Communication | 1 | 2020 | 201 | 0.140 |
Why?
| | Caregivers | 3 | 2024 | 1041 | 0.140 |
Why?
| | Health Services Research | 3 | 2016 | 394 | 0.140 |
Why?
| | Healthcare Disparities | 1 | 2025 | 712 | 0.140 |
Why?
| | Adenine | 1 | 2021 | 334 | 0.140 |
Why?
| | Foundations | 1 | 2018 | 27 | 0.140 |
Why?
| | Gender Identity | 1 | 2019 | 125 | 0.140 |
Why?
| | Suicidal Ideation | 2 | 2015 | 557 | 0.130 |
Why?
| | Program Evaluation | 5 | 2021 | 962 | 0.130 |
Why?
| | Chi-Square Distribution | 3 | 2012 | 517 | 0.130 |
Why?
| | Attitude to Health | 2 | 2017 | 436 | 0.130 |
Why?
| | Hospital Costs | 2 | 2012 | 122 | 0.130 |
Why?
| | Program Development | 1 | 2019 | 370 | 0.130 |
Why?
| | Sexism | 1 | 2018 | 70 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2013 | 2037 | 0.130 |
Why?
| | Hospitalization | 2 | 2011 | 2359 | 0.130 |
Why?
| | Reminder Systems | 1 | 2017 | 147 | 0.120 |
Why?
| | Public Health Administration | 1 | 1997 | 73 | 0.120 |
Why?
| | Immunization | 1 | 2017 | 375 | 0.120 |
Why?
| | Leadership | 1 | 2020 | 408 | 0.120 |
Why?
| | Risk Factors | 8 | 2012 | 10672 | 0.110 |
Why?
| | Veterans | 1 | 2007 | 1600 | 0.110 |
Why?
| | Alcoholism | 1 | 2002 | 814 | 0.110 |
Why?
| | Florida | 2 | 2025 | 116 | 0.110 |
Why?
| | Community Mental Health Services | 2 | 2007 | 87 | 0.100 |
Why?
| | Comorbidity | 3 | 2015 | 1640 | 0.100 |
Why?
| | Accidents | 2 | 2005 | 45 | 0.100 |
Why?
| | Quetiapine Fumarate | 1 | 2013 | 24 | 0.100 |
Why?
| | Oregon | 1 | 2013 | 77 | 0.100 |
Why?
| | Health Information Management | 1 | 2013 | 7 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 432 | 0.100 |
Why?
| | Alcohol-Related Disorders | 2 | 2005 | 121 | 0.100 |
Why?
| | Health Expenditures | 2 | 2006 | 191 | 0.100 |
Why?
| | Patient Satisfaction | 1 | 2017 | 712 | 0.100 |
Why?
| | Minority Groups | 2 | 2022 | 283 | 0.100 |
Why?
| | Decision Support Techniques | 2 | 2014 | 447 | 0.100 |
Why?
| | Medical Audit | 1 | 2013 | 76 | 0.100 |
Why?
| | Age Factors | 5 | 2012 | 3311 | 0.100 |
Why?
| | Analysis of Variance | 2 | 2014 | 1309 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 711 | 0.090 |
Why?
| | Regression Analysis | 3 | 2011 | 1003 | 0.090 |
Why?
| | Women's Health Services | 2 | 2006 | 15 | 0.090 |
Why?
| | Medical Records Systems, Computerized | 1 | 2013 | 96 | 0.090 |
Why?
| | Economics, Pharmaceutical | 1 | 2012 | 10 | 0.090 |
Why?
| | Education, Pharmacy, Graduate | 1 | 2012 | 12 | 0.090 |
Why?
| | Interviews as Topic | 2 | 2020 | 898 | 0.090 |
Why?
| | Diagnostic Tests, Routine | 1 | 2013 | 110 | 0.090 |
Why?
| | Efficiency | 1 | 2012 | 103 | 0.090 |
Why?
| | Education, Graduate | 1 | 2012 | 36 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 127 | 0.090 |
Why?
| | Health Services | 1 | 2012 | 116 | 0.090 |
Why?
| | Prevalence | 3 | 2011 | 2830 | 0.090 |
Why?
| | Advisory Committees | 3 | 2007 | 208 | 0.090 |
Why?
| | Pilot Projects | 2 | 2024 | 1873 | 0.090 |
Why?
| | Psychomotor Agitation | 1 | 2011 | 45 | 0.090 |
Why?
| | Self Care | 1 | 2014 | 399 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 175 | 0.090 |
Why?
| | Patient-Centered Care | 1 | 2016 | 544 | 0.090 |
Why?
| | State Health Plans | 2 | 2002 | 28 | 0.090 |
Why?
| | Nausea | 1 | 2011 | 112 | 0.090 |
Why?
| | Referral and Consultation | 1 | 2017 | 847 | 0.090 |
Why?
| | Interinstitutional Relations | 1 | 2011 | 52 | 0.080 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2012 | 93 | 0.080 |
Why?
| | Infant, Small for Gestational Age | 1 | 2012 | 110 | 0.080 |
Why?
| | Vomiting | 1 | 2011 | 131 | 0.080 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2012 | 89 | 0.080 |
Why?
| | Sexual Dysfunction, Physiological | 1 | 2011 | 74 | 0.080 |
Why?
| | Policy Making | 1 | 2011 | 83 | 0.080 |
Why?
| | Drug Labeling | 2 | 2007 | 36 | 0.080 |
Why?
| | Employment | 1 | 2012 | 186 | 0.080 |
Why?
| | Headache | 1 | 2011 | 153 | 0.080 |
Why?
| | Radiography, Interventional | 1 | 2012 | 127 | 0.080 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2011 | 100 | 0.080 |
Why?
| | Medicare | 3 | 2024 | 825 | 0.080 |
Why?
| | Computer Communication Networks | 1 | 2010 | 32 | 0.080 |
Why?
| | Medication Adherence | 1 | 2014 | 523 | 0.080 |
Why?
| | Social Support | 2 | 2020 | 653 | 0.080 |
Why?
| | Heart Transplantation | 1 | 2016 | 733 | 0.080 |
Why?
| | Influenza, Human | 2 | 2017 | 615 | 0.080 |
Why?
| | Life Style | 1 | 2012 | 486 | 0.070 |
Why?
| | California | 3 | 2007 | 467 | 0.070 |
Why?
| | Proportional Hazards Models | 3 | 2015 | 1307 | 0.070 |
Why?
| | Drug Utilization Review | 1 | 2009 | 59 | 0.070 |
Why?
| | Vaccination | 1 | 2017 | 1423 | 0.070 |
Why?
| | Information Dissemination | 1 | 2011 | 219 | 0.070 |
Why?
| | Financing, Government | 2 | 2000 | 52 | 0.070 |
Why?
| | Residence Characteristics | 1 | 2012 | 375 | 0.070 |
Why?
| | Community-Institutional Relations | 1 | 2009 | 102 | 0.070 |
Why?
| | Drug Prescriptions | 2 | 2007 | 271 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 373 | 0.070 |
Why?
| | Surveys and Questionnaires | 4 | 2020 | 6052 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2012 | 351 | 0.070 |
Why?
| | Absorptiometry, Photon | 1 | 2009 | 277 | 0.070 |
Why?
| | HIV Infections | 2 | 2021 | 3082 | 0.070 |
Why?
| | Prospective Studies | 3 | 2021 | 7947 | 0.070 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2007 | 43 | 0.070 |
Why?
| | Office Visits | 1 | 2007 | 91 | 0.070 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 779 | 0.060 |
Why?
| | Trauma Severity Indices | 2 | 2005 | 110 | 0.060 |
Why?
| | Drug Utilization | 1 | 2007 | 163 | 0.060 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 223 | 0.060 |
Why?
| | Databases, Factual | 4 | 2016 | 1474 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2012 | 6406 | 0.060 |
Why?
| | Physicians, Family | 1 | 2007 | 174 | 0.060 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2005 | 37 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 782 | 0.060 |
Why?
| | Cost Savings | 2 | 2012 | 85 | 0.060 |
Why?
| | Bone Density | 1 | 2009 | 501 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2008 | 281 | 0.050 |
Why?
| | Alcohol Drinking | 1 | 2012 | 832 | 0.050 |
Why?
| | Sleep | 1 | 2011 | 909 | 0.050 |
Why?
| | Psychiatry | 1 | 2007 | 187 | 0.050 |
Why?
| | Pregnancy | 2 | 2020 | 7197 | 0.050 |
Why?
| | Northwestern United States | 1 | 2004 | 57 | 0.050 |
Why?
| | Southwestern United States | 1 | 2004 | 95 | 0.050 |
Why?
| | Brain Damage, Chronic | 1 | 2003 | 18 | 0.050 |
Why?
| | Direct Service Costs | 1 | 2003 | 7 | 0.050 |
Why?
| | Age of Onset | 1 | 2005 | 544 | 0.050 |
Why?
| | Volition | 1 | 2003 | 34 | 0.050 |
Why?
| | Tobacco Use Disorder | 1 | 2005 | 223 | 0.050 |
Why?
| | Odds Ratio | 2 | 2004 | 1058 | 0.050 |
Why?
| | Sampling Studies | 1 | 2003 | 100 | 0.050 |
Why?
| | Monte Carlo Method | 2 | 2014 | 155 | 0.050 |
Why?
| | Somatoform Disorders | 1 | 2003 | 35 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 3165 | 0.050 |
Why?
| | Marijuana Abuse | 1 | 2005 | 213 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2013 | 11581 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2007 | 588 | 0.050 |
Why?
| | Rehabilitation, Vocational | 1 | 2002 | 3 | 0.050 |
Why?
| | Cost Allocation | 1 | 2002 | 7 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 105 | 0.050 |
Why?
| | Factor Analysis, Statistical | 1 | 2003 | 292 | 0.040 |
Why?
| | Calcium Channel Blockers | 1 | 2022 | 165 | 0.040 |
Why?
| | Child Health Services | 2 | 2001 | 184 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 193 | 0.040 |
Why?
| | Reimbursement, Incentive | 1 | 2002 | 41 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2009 | 3628 | 0.040 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2022 | 225 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 141 | 0.040 |
Why?
| | Practice Management, Medical | 1 | 2001 | 30 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2002 | 331 | 0.040 |
Why?
| | Qualitative Research | 2 | 2020 | 1656 | 0.040 |
Why?
| | Data Interpretation, Statistical | 1 | 2003 | 371 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 2007 | 690 | 0.040 |
Why?
| | Occupational Diseases | 1 | 2002 | 164 | 0.040 |
Why?
| | Adolescent Behavior | 1 | 2005 | 521 | 0.040 |
Why?
| | International Classification of Diseases | 2 | 2015 | 140 | 0.040 |
Why?
| | Incidence | 2 | 2005 | 2865 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 1086 | 0.040 |
Why?
| | Pediatrics | 1 | 2007 | 1099 | 0.040 |
Why?
| | Health Care Surveys | 2 | 1997 | 536 | 0.040 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 89 | 0.040 |
Why?
| | Models, Statistical | 1 | 2003 | 680 | 0.040 |
Why?
| | Risk Assessment | 3 | 2015 | 3580 | 0.030 |
Why?
| | Social Stigma | 1 | 2020 | 158 | 0.030 |
Why?
| | Career Choice | 1 | 2019 | 237 | 0.030 |
Why?
| | Competitive Bidding | 1 | 1997 | 3 | 0.030 |
Why?
| | Administrative Personnel | 1 | 1997 | 31 | 0.030 |
Why?
| | Decision Making, Organizational | 1 | 1997 | 26 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2014 | 3854 | 0.030 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 104 | 0.030 |
Why?
| | Pneumococcal Vaccines | 1 | 2017 | 129 | 0.030 |
Why?
| | Specialization | 2 | 2007 | 134 | 0.030 |
Why?
| | Motivation | 1 | 2001 | 607 | 0.030 |
Why?
| | National Institute of Mental Health (U.S.) | 1 | 2016 | 4 | 0.030 |
Why?
| | Models, Organizational | 1 | 1997 | 147 | 0.030 |
Why?
| | Immunization Programs | 1 | 2017 | 193 | 0.030 |
Why?
| | Citalopram | 1 | 2015 | 33 | 0.030 |
Why?
| | Medicine | 2 | 2007 | 125 | 0.030 |
Why?
| | Fluoxetine | 1 | 2015 | 54 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 283 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 576 | 0.030 |
Why?
| | Treatment Failure | 1 | 2015 | 364 | 0.030 |
Why?
| | Uncertainty | 1 | 2014 | 144 | 0.030 |
Why?
| | Urban Population | 1 | 1997 | 493 | 0.030 |
Why?
| | Probability | 1 | 2014 | 306 | 0.030 |
Why?
| | American Recovery and Reinvestment Act | 1 | 2013 | 6 | 0.020 |
Why?
| | Reoperation | 1 | 2016 | 614 | 0.020 |
Why?
| | Insurance Claim Review | 1 | 2013 | 83 | 0.020 |
Why?
| | Influenza Vaccines | 1 | 2017 | 528 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1033 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 860 | 0.020 |
Why?
| | Schools, Pharmacy | 1 | 2012 | 47 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2014 | 227 | 0.020 |
Why?
| | Databases as Topic | 1 | 2011 | 68 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 81 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1999 | 936 | 0.020 |
Why?
| | Models, Economic | 1 | 2012 | 61 | 0.020 |
Why?
| | Faculty | 1 | 2012 | 151 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 209 | 0.020 |
Why?
| | Health Care Rationing | 1 | 2011 | 58 | 0.020 |
Why?
| | Propensity Score | 1 | 2011 | 364 | 0.020 |
Why?
| | Patient Discharge | 1 | 2016 | 949 | 0.020 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 157 | 0.020 |
Why?
| | Legislation, Medical | 1 | 2007 | 11 | 0.020 |
Why?
| | Poverty Areas | 1 | 2007 | 41 | 0.020 |
Why?
| | Crisis Intervention | 1 | 2007 | 35 | 0.020 |
Why?
| | Computer Simulation | 1 | 2012 | 1035 | 0.020 |
Why?
| | Appointments and Schedules | 1 | 2007 | 98 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2006 | 77 | 0.020 |
Why?
| | Ontario | 1 | 2006 | 94 | 0.020 |
Why?
| | Students | 1 | 2012 | 670 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2517 | 0.010 |
Why?
| | Osteoporosis | 1 | 2009 | 245 | 0.010 |
Why?
| | Health Status Indicators | 1 | 2006 | 162 | 0.010 |
Why?
| | Time Factors | 1 | 2016 | 7107 | 0.010 |
Why?
| | Seasons | 1 | 2007 | 556 | 0.010 |
Why?
| | Drug Monitoring | 1 | 2007 | 396 | 0.010 |
Why?
| | Pandemics | 1 | 2011 | 1685 | 0.010 |
Why?
| | Physician Incentive Plans | 1 | 2000 | 8 | 0.010 |
Why?
| | Cost Control | 1 | 2000 | 37 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2005 | 980 | 0.010 |
Why?
| | Adolescent Health Services | 1 | 2001 | 75 | 0.010 |
Why?
| | Multicenter Studies as Topic | 1 | 2002 | 399 | 0.010 |
Why?
| | Health Care Reform | 1 | 2000 | 108 | 0.010 |
Why?
| | Workplace | 1 | 2002 | 274 | 0.010 |
Why?
| | Primary Prevention | 1 | 2000 | 197 | 0.010 |
Why?
| | Interpersonal Relations | 1 | 2002 | 405 | 0.010 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 1999 | 76 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 5350 | 0.010 |
Why?
| | Quality Indicators, Health Care | 1 | 2000 | 310 | 0.010 |
Why?
| | Lymphatic Metastasis | 1 | 1999 | 337 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 772 | 0.010 |
Why?
| | Patient Care Team | 1 | 2002 | 686 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2002 | 1701 | 0.010 |
Why?
| | Prognosis | 1 | 1999 | 4253 | 0.000 |
Why?
|
|
Libby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|